Part of Thermo Fisher Scientific

Olink is now part of Thermo Fisher Scientific

OlinkOlink Target 48

New Immune Surveillance panel now available. Perform immune biomarker profiling with absolute confidence.

OlinkOlink Insight

Journey from experiment planning and study design to post-run data analysis – in a single online bioinformatic app.

Landmark articles in Nature 
show the power of population-scale proteogenomics


Read the latest impressive findings from the UK Biobank Pharma Proteomics Project.

Empowering genomics with high-throughput proteomics


Explore recent advancements in our pioneering field. Discover how top scientists use high-throughput proteomics to advance precision medicine.

One platform. 
Endless possibilities.

PEA Technology

Meet the next-generation proteomics platform trusted by small lab teams and leading pharma companies.

Olink Proteomics World


Join us on September 26, 2024 to learn more about proteomics in drug development, biomarker discovery & clinical translation, and proteogenomics.

Latest news

Stay updated with the latest Olink news, including press releases, events, and notable publications describing cutting-edge research and key advancements in proteomics.